Quoin Pharmaceuticals Ltd.
13F holders, Q2 2024 (June 30)10holders +2
5new positions
3sold out
1famous investor
$0.58avg. 13F price*
At the end of Q2 2024, 10 institutions reported holding Quoin Pharmaceuticals Ltd. in their 13F filings, up 2 from Q1 2024. 5 opened new positions and 3 sold out. The largest holders were Altium Capital Management LLC ($60K), Renaissance Technologies ($20K) and Two Sigma Securities, LLC ($14K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Quoin Pharmaceuticals Ltd.
- CUSIP
- 74907L300
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $36K |
| Exits | 3 | $67K |
All 13F filers, Q1 2024 → Q2 2024: 110,084 shares bought and 84,162 shares sold, net +25,922 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Altium Capital Management LLC | 0.02% | Add +55.7% | 103,127 | $60K |
| Renaissance Technologies | 0.00% | Reduce -26.5% | 34,200 | $20K |
| Two Sigma Securities, LLC | 0.00% | New | 23,460 | $14K |
| Susquehanna International Group, LLP | 0.00% | New | 15,431 | $9K |
| Rhumbline Advisers | 0.00% | Add +289.3% | 14,791 | $9K |
| Two Sigma Investments, LP | 0.00% | New | 10,922 | $6K |
| OneDigital Investment Advisors LLC | 0.00% | New | 10,400 | $6K |
| UBS Group AG | 0.00% | Add +19.4% | 6,097 | $4K |
| Bank of America Corp. | 0.00% | New | 1,000 | $580 |
| JPMorgan Chase & Co. | 0.00% | No change | 645 | $375 |
"% of holder's portfolio" is QUOIN PHARMACEUTICALS LTD's weight in each manager's 13F, not the share of Quoin Pharmaceuticals Ltd. the manager owns.